Skip to main content

Table 3 Blood glucose level obtained during the OGTT before and after supplementation with AHE or placeboa

From: A randomized, double-blind, placebo-controlled crossover clinical trial to evaluate the anti-diabetic effects of Allium hookeri extract in the subjects with prediabetes

  Test group (n = 22) Placebo group (n = 22) P-valueb
Week 0 Week 8 Change value Week 0 Week 8 Change value
Blood glucose (mg/dL) 0 min 106.91 ± 7.21 107.55 ± 10.66 0.64 ± 8.51 108.55 ± 9.77 107.77 ± 10.43 −0.77 ± 7.56 0.569
30 min 182.36 ± 27.14 183.32 ± 20.41 0.95 ± 20.58 186.95 ± 28.25 187.64 ± 23.65 0.68 ± 27.52 0.968
60 min 216.86 ± 32.74 216.18 ± 46.24 −0.68 ± 32.57 197.77 ± 39.54 216.27 ± 46.07 18.50 ± 33.20 0.040
90 min 211.59 ± 50.02 209.27 ± 46.28 −2.32 ± 37.57 192.45 ± 44.93 214.45 ± 56.48 22.00 ± 55.40 0.149
120 min 196.77 ± 48.95 192.32 ± 44.99 −4.45 ± 39.49 182.82 ± 47.79 195.09 ± 51.71 12.27 ± 47.65 0.282
iAUC0–2 h (h*mg/dL) 167.51 ± 55.92 164.26 ± 57.42 −3.25 ± 38.59 144.37 ± 43.54 169.35 ± 63.80 24.98 ± 45.15 0.040
  1. OGTT oral glucose tolerance test; AHE Allium hookeri extract; iAUC incremental area under the curve
  2. aValues are presented as mean ± standard deviation
  3. bAnalyzed using t-test (difference between two groups in change from baseline)